Greenleaf Health is a full service regulatory consulting firm that provides strategic guidance to companies regulated by the Food and Drug Administration that are developing innovative solutions to pressing public health challenges around the globe.
The Greenleaf team includes former leaders from FDA, Capitol Hill, top global pharmaceutical companies and the leading U.S. biotechnology trade organization.
This wealth of experience allows the Greenleaf team to understand the broad health care industry, while appreciating the business challenges facing health care companies in a rapidly changing environment.
Greenleaf Health consults on strategic regulatory matters for a select group of healthcare sector clients, including pharmaceutical, biotechnology and medical device companies.
Greenleaf’s regulatory guidance services include product lifecycle management, product approval, product labeling, manufacturing & compliance, marketing & promotional practices, and regulatory policy.
Clients choose Greenleaf for strategic guidance because the firm has a rare blend of experience in both the public and private sectors,equipping it with the expertise necessary to assist health care clients in making critical, real-time business decisions.
With experience in both the private and public sectors, Greenleaf harnesses its extensive institutional knowledge of the FDA in order to provide clients with insightful strategic guidance.
For more information on the comprehensive services offered by Greenleaf Health, click here.